Kimberly A. Reske

3.5k total citations
58 papers, 2.6k citations indexed

About

Kimberly A. Reske is a scholar working on Infectious Diseases, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Kimberly A. Reske has authored 58 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 27 papers in Epidemiology and 15 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Kimberly A. Reske's work include Clostridium difficile and Clostridium perfringens research (41 papers), Microscopic Colitis (23 papers) and Nosocomial Infections in ICU (15 papers). Kimberly A. Reske is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (41 papers), Microscopic Colitis (23 papers) and Nosocomial Infections in ICU (15 papers). Kimberly A. Reske collaborates with scholars based in United States, India and Japan. Kimberly A. Reske's co-authors include Erik R. Dubberke, Victoria J. Fraser, Margaret A. Olsen, L. Clifford McDonald, Yan Yan, Da Hea Seo, Christian D. Stone, Carey‐Ann D. Burnham, Tiffany Hink and Jennie H. Kwon and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Kimberly A. Reske

56 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly A. Reske United States 25 2.0k 1.6k 557 505 407 58 2.6k
Julia Shaklee Sammons United States 16 2.8k 1.4× 2.1k 1.3× 675 1.2× 744 1.5× 443 1.1× 41 3.4k
André Dascal Canada 19 3.0k 1.5× 2.2k 1.4× 625 1.1× 658 1.3× 347 0.9× 43 3.6k
Anne–Marie Bourgault Canada 26 2.9k 1.4× 2.2k 1.4× 589 1.1× 645 1.3× 360 0.9× 60 3.9k
Erin C. Phipps United States 15 2.9k 1.5× 2.0k 1.3× 629 1.1× 708 1.4× 511 1.3× 26 3.3k
Carlene A. Muto United States 23 2.3k 1.2× 1.7k 1.1× 598 1.1× 420 0.8× 277 0.7× 38 3.3k
Matthew Oughton Canada 11 2.2k 1.1× 1.6k 1.0× 535 1.0× 481 1.0× 211 0.5× 21 2.5k
Robin Jump United States 27 1.2k 0.6× 1.4k 0.9× 351 0.6× 250 0.5× 298 0.7× 110 2.7k
Moe H. Kyaw United States 29 878 0.4× 2.4k 1.5× 260 0.5× 622 1.2× 320 0.8× 67 3.7k
Martijn P. Bauer Netherlands 22 3.4k 1.7× 2.4k 1.5× 615 1.1× 728 1.4× 480 1.2× 39 3.7k
Lisa G. Winston United States 20 3.5k 1.7× 2.5k 1.6× 813 1.5× 868 1.7× 605 1.5× 47 4.1k

Countries citing papers authored by Kimberly A. Reske

Since Specialization
Citations

This map shows the geographic impact of Kimberly A. Reske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly A. Reske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly A. Reske more than expected).

Fields of papers citing papers by Kimberly A. Reske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly A. Reske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly A. Reske. The network helps show where Kimberly A. Reske may publish in the future.

Co-authorship network of co-authors of Kimberly A. Reske

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly A. Reske. A scholar is included among the top collaborators of Kimberly A. Reske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly A. Reske. Kimberly A. Reske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reske, Kimberly A., Daniel Park, Olivia G. Arter, et al.. (2023). Personal protective equipment use among dental healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic and the impact of an educational video in clinical practice. Infection Control and Hospital Epidemiology. 44(9). 1472–1480. 3 indexed citations
2.
Kwon, Jennie H., Katelin B. Nickel, Kimberly A. Reske, et al.. (2023). Risk factors for hospital-onset Clostridioides difficile infections before and during the severe acute respiratory syndrome coronavirus 2 pandemic. American Journal of Infection Control. 51(11). 1285–1287. 2 indexed citations
3.
Nickel, Katelin B., Dustin Stwalley, Kimberly A. Reske, et al.. (2023). Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients. Infection Control and Hospital Epidemiology. 44(12). 1966–1971. 2 indexed citations
4.
Mahmud, Bejan, Meghan A. Wallace, Kimberly A. Reske, et al.. (2022). Epidemiology of Plasmid Lineages Mediating the Spread of Extended-Spectrum Beta-Lactamases among Clinical Escherichia coli. mSystems. 7(5). e0051922–e0051922. 18 indexed citations
5.
Bailey, Adam L., David McDonald, Meghan A. Wallace, et al.. (2022). Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results. Frontiers in Cellular and Infection Microbiology. 12. 804175–804175. 16 indexed citations
6.
Fishbein, Skye R. S., Tiffany Hink, Kimberly A. Reske, et al.. (2021). Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients. mSphere. 6(1). 24 indexed citations
7.
Kwon, Jennie H., Kimberly A. Reske, Caroline A. O’Neil, et al.. (2020). Assessment of antibiotic-resistant organism transmission among rooms of hospitalized patients, healthcare personnel, and the hospital environment utilizing surrogate markers and selective bacterial cultures. Infection Control and Hospital Epidemiology. 41(5). 539–546. 2 indexed citations
8.
Kwak, Suryang, JooHee Choi, Tiffany Hink, et al.. (2020). Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial. Microbiome. 8(1). 125–125. 44 indexed citations
9.
Rauseo, Adriana M., Margaret A. Olsen, Kimberly A. Reske, & Erik R. Dubberke. (2020). Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly. Expert Review of Anti-infective Therapy. 18(3). 203–217. 3 indexed citations
10.
Thänert, Robert, Kimberly A. Reske, Tiffany Hink, et al.. (2019). Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections. mBio. 10(4). 80 indexed citations
11.
Robinson, John I., William H. Weir, Jan R. Crowley, et al.. (2019). Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections. Journal of Clinical Investigation. 129(9). 3792–3806. 62 indexed citations
12.
Langdon, Amy, Tiffany Hink, Meghan A. Wallace, et al.. (2018). Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential. mSphere. 3(6). 15 indexed citations
13.
Dubberke, Erik R., Kimberly A. Reske, Margaret A. Olsen, et al.. (2018). Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients. Transplant Infectious Disease. 20(2). e12855–e12855. 27 indexed citations
14.
Kwon, Jennie H., Kimberly A. Reske, Tiffany Hink, et al.. (2017). An Evaluation of the Prevalence of Vancomycin-Resistant Enterococci (VRE) and Methicillin-Resistant Staphylococcus aureus (MRSA) in Hospital Food. Infection Control and Hospital Epidemiology. 38(11). 1373–1375. 4 indexed citations
15.
Kwon, Jennie H., Kimberly A. Reske, Tiffany Hink, Carey‐Ann D. Burnham, & Erik R. Dubberke. (2016). Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results. Journal of Clinical Microbiology. 55(2). 596–605. 11 indexed citations
16.
Dubberke, Erik R., Kimberly A. Reske, Sondra Seiler, et al.. (2015). Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients. Antimicrobial Agents and Chemotherapy. 59(8). 4533–4543. 51 indexed citations
17.
Zilberberg, Marya D., Kimberly A. Reske, Margaret A. Olsen, Yan Yan, & Erik R. Dubberke. (2014). Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infectious Diseases. 14(1). 306–306. 50 indexed citations
18.
Dubberke, Erik R., Kimberly A. Reske, Margaret A. Olsen, L. Clifford McDonald, & Victoria J. Fraser. (2008). Short- and Long-Term Attributable Costs of Clostridium difficile-Associated Disease in Nonsurgical Inpatients. Clinical Infectious Diseases. 46(4). 497–504. 146 indexed citations
19.
Dubberke, Erik R., Anne M. Butler, Kimberly A. Reske, et al.. (2008). Attributable Outcomes of EndemicClostridium difficile–associated Disease in Nonsurgical Patients. Emerging infectious diseases. 14(7). 1031–1038. 133 indexed citations
20.
Dubberke, Erik R., et al.. (2007). Incidence of Clostridium difficile Infection in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 5(3). 339–344. 386 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026